Call for Papers

Journal of Ocular Pharmacology and Therapeutics

Editor-in-Chief: W. Daniel Stamer, PhD

The Journal is currently seeking high-quality, innovative submissions to be published in upcoming issues!

Areas of focus can include, but are not limited to:

  • Glaucoma
  • Cataracts
  • Retinal degeneration
  • Ocular infection, trauma, and toxicology
  • Ocular drug delivery and biotransformation
  • Ocular pharmacotherapy/clinical trials
  • Ocular inflammatory and immune disorders
  • Gene and cell-based therapies
  • Ocular metabolic disorders
  • Ocular ischemia and bloow flow
  • Proliferative disorders of the eye

Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders.

Benefits of publishing in the Journal include:

  • Rapid, high-quality peer review
  • Fast and user-friendly electronic submission
  • Diversity of article types
  • Maximum exposure: readership in more than 170 countries
  • Open Access options available

Learn More about this journal

Deadline for Manuscript Submission:
December 31, 2017